Quality of Recovery of Remimazolam Versus Sevoflurane in Transurethral Bladder Resection.

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 2, 2022

Primary Completion Date

February 24, 2023

Study Completion Date

February 24, 2023

Conditions
Quality of Recovery
Interventions
DRUG

Sevoflurane

Sevoflurane is chosen as an anesthetic agent for general anesthesia. General anesthesia for the patients in this group will be induced with propofol (1-1.5 mg/kg), and will be maintained with sevoflurane to keep patient state index of 25-50.

DRUG

Remimazolam

Remimazolam is chosen as an anesthetic agent for general anesthesia. General anesthesia for the patients in this group will be induced with remimazolam, and will be maintained with remimazolam to keep patient state index of 25-50.

Trial Locations (1)

03181

Eunah Cho, Seoul

All Listed Sponsors
collaborator

Hana Pharm Co., Ltd.

INDUSTRY

lead

Kangbuk Samsung Hospital

OTHER